TheBioPunkRevenger
$BNGO
Prenatal OGM just got a practical workflow upgrade.
Peking Union study (Molecular Cytogenetics): 199 consecutive prenatal samples. OGM ran clean on inputs as low as 0.225 million amniotic fluid cells — well below standard kit recommendations. 96.9% concordance with karyotype + microarray. In 74 of the positive cases it added breakpoint resolution, orientation, and fusion detail the older stack missed.
This is one of the higher-probability non-heme lines on the menu. Prenatal volume is real. Lower cell input + shorter culture time removes a friction point that has kept mapping out of many prenatal workflows.
Heme 81195 is already live and paid. Constitutional 81354 is live. NYSDOH LDTs are cleared. MolDX heme draft is out. Now prenatal shows it can run on the thin samples labs actually get.
Street models are still pricing mostly one heme kit. The menu keeps expanding with real clinical data. That’s the flywheel. The distribution is still wrong.
1

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault13.jpg)